logo

INmune Bio Inc (INMB) Stock: Navigating Market Highs and Lows in 52 Weeks

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. INmune Bio Inc’s current trading price is -27.92% away from its 52-week high, while its distance from the 52-week low is 63.46%. The stock’s price range during this period has varied between $6.50 and $14.74. The company, active in the Healthcare sector, saw a trading volume of around 0.68 million for the day, considerably higher average daily volume of 87400.0 observed over the last three months.

INmune Bio Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $14.74 on 02/14/24, and the lowest price during the same period was recorded at $6.50 on 09/20/23.

How Financial Performance Impacts Market Capitalization

INmune Bio Inc (INMB) has experienced a quarterly decline of -4.88% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 193.38M and boasts a workforce of 17 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 11.36, with a change in price of +1.26. Similarly, INmune Bio Inc recorded 92,542 in trading volume during the last 100 days, posting a change of +13.39%.

How INMB’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for INMB stands at 0.27. Similarly, the long-term debt-to-equity ratio is also 0.01.

INMB Stock Stochastic Average

As of today, the raw stochastic average of INmune Bio Inc over the past 50 days is 36.10%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 55.62%. Additionally, the Stochastic %K and %D values for the company were 22.51% and 11.19%, respectively, over the past 20 days.

INMB Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -5.64%.However, over the last six months, we can see a weaker performance of 42.24%. Over the last 30 days, the price of INMB has leaped by -10.86%. And in the last five days, it has surged by 10.91%.

Most Popular